ArticleEuropean journal of nuclear medicine and molecular imaging2018

Correction to: Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis.

Sue Ping Thang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.